News
Read what's happening in Ampersand's Portfolio.
September 15, 2008
FDA Grants Approval to Talecris Biotherapeutics for Gamunex® as a Treatment for Neurological Disorder CIDP in the United States
August 29, 2008
Ampersand Ventures leads recapitalization of MedVenture Technology Corporation
August 21, 2008
Signature Genomic Laboratories Named to Inc. 5000
August 12, 2008
Talecris Enters into Definitive Merger Agreement with CSL
July 17, 2008
ChanTest to Highlight the World’s Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Drug Discovery Technology, Booth 839
July 1, 2008
IBT Laboratories Names Maureen Loftus President and Chief Operating Officer
June 24, 2008
Signature Reports Investment in Company and Appointment of New Chairman of Board of Directors
June 16, 2008
Talecris Biotherapeutics, Inc. Provides Business Update
May 29, 2008
Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
May 15, 2008
Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays
May 08, 2008
FDA Grants Priority Review of Gamunex® as a Treatment for Neurological Disorder CIDP
April 29, 2008
Endeca Named One of Massachusetts’s Fastest Growing Private Company in Boston Business Journal Annual Ranking
March 26, 2008
Significant award further enhances MEDIFACTS’ position as one of the top cardiac safety services providers
January 23, 2008
Endeca Receives Investment from SAP Ventures
January 23, 2008
Intel Capital Invests $10 Million in Endeca
January 10, 2008
Signature microarray covers regions of the genome associated with autism
January 5, 2008
Ampersand Ventures Announces Acquisition of K-TEK Corporation, a Leading Supplier of Level Measurement Instrumentation to the Process Industries